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Progressive hypoalbuminemia during continuous ambulatory peritoneal
dialysis: single centre report
D. Leung, T.C. Au
Renal Unit, Department of Medicine, Tuen Mun Hospital, Hong Kong.
Background: Hypoalbuminemia is an independent risk factor for mortality
and is associated with malnutrition. One of the factors involved in the etiology
of hypoalbuminemia and malnutrition is dialysate protein loss during CAPD.
Objective: We report the characteristic of serum albumin, one of the nutritional
indicators, in patients with the course of CAPD for at least 5 years. Methods:
A retrospective analysis was done on CAPD patients who started CAPD during
1 May 1993 to 31 December 1997. The serum albumin level was monitored for
5 years. Results: 56 patients were included. All were on CAPD with Dianeal.
Age, gender, and peritoneal transporter status distribution were normal. There
was no significant difference in the serum albumin and residual renal function
on commencement of CAPD. Serum albumin decreased with time. The decrease
is marked at the 5th year. Thirteen (23%) patients died in the 6th year.
Year Average serum albumin at the end of Year...
recruit 0 1 2 3 4 5
1993 36 35.7 34.5 34.7 34.3 32.2
1994 35.5 35.3 36 35 35 33
1995 36 35.3 36 35 35 32.2
1996 36.8 34.9 34.4 34.2 34.1 32.2
1997 36 35.2 35.5 35 35 32.2
Conclusions: Hypoalbuminemia sets in with progression of CAPD. Whether a
timely use of amino acid dialysis solution for hypoalbuminemia benefits in
maintaining nutrition with improving survival on CAPD may deserve
consideration.
Dietary phosphorus control in ESRD patients on hemodialysis (HD):
nursing perspectives
D. Leung, S.W. Mak, K.F. So, B. Yeung
Renal Unit, Department of Medicine, Tuen Mun Hospital, Hong Kong.
Background: Uremic calcification sets in with increased serum phosphorus
during the progression of renal failure. Blood biochemistries of all patients on
regular HD in the locality are audited monthly to allow early medical
management and nursing intervention. Objective: Recognizing dietary intake
constitutes the source of phosphorus, this study aimed (1) to identify dietary
characteristics of HD patients with suboptimal phosphate control despite drug
therapy and continuous education, (2) to formulate nursing action plans for
better dietary phosphorus controls. Methods: Blood results of all stable HD
patients during the period September 2003 to August 2004 were censored. GpA
patients had an average serum phosphate exceeding 2.2 mmol/L. Those below
2.2 were included in GpB. All were censored by the ‘Appetite and Diet
Assessment tool for use with HD patients’. Results: There were13 patients in
each group with normal age and gender distributions, all adequately dialyzed
and anemia optimally corrected. All claimed good drug compliance and adequate
knowledge on phosphorus restriction. Average serum calcium/ phosphate was
2.44/2.60 and 2.42/1.80mmol/L in GpA and in GpB. The frequency of eating-
out were comparable. 54% in Gp A while 85% in GpB rated their appetite very
good or good, others rated fair or poor. 61.5% in GpA and 15% in GpB cooked
by themselves and eat with others. There was no significant difference in the
habit of taking snacks between meals in the two groups. Conclusions:
Appropriate suggestions on cooking habits with enforcement in phosphorus
control may be a determinant nursing intervention in uremic calcification control
for HD patients. The psychosocial element of cooking to eat ‘normally’ with
others may be an area for research.
Effect of pre-dialysis education class on patients suffering from chronic
kidney disease: role of nephrologists in pre-dialysis renal care
W.L. Chak, K.F. Chau, K.S. Choi, F.K.M. Wong, Y.H. Chan, C.Y. Cheung,
H.S. Wong, Y.L. Liu, C.S. Li
Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong.
Objective: Regular pre-dialysis education classes (PEC) were delivered to
patients suffering from chronic kidney disease (CKD) before the start of routine
dialysis in a regional hospital. We assessed the effect of PEC on CKD patients.
Methods: This was a prospective observational study. 12 PECs were organized
from 1996 to 2000. 107 (44 male, 63 female) CKD patients and their families
who attended PEC (group A) were compared with 285 CKD patients (147 male,
138 female) who did not attend PEC (group B) before their enrollment into the
CAPD program. Both groups underwent the same structured PD training after
Tenckhoff catheter insertion. Patients were evaluated at the break-in period,
and 3 and 6 months after the commencement of routine dialysis. Results: During
the break-in period, the requirements of intermittent hemodialysis (IHD) support
and hospitalization rate (HR) were significantly higher in group B when
compared with group A (IHD: 4.6 ( 6.6 in group A and 6.7 ( 8.2 in group B,
p < 0.01; HR: 12.2 ( 13.7 days in group A and 20.5 ( 16.1 days in group B,
p = 0.02). There were also more non-scheduled nephrologist consultations
(NSFU) in group B patients, both at 3 and 6 months after commencement of
PD, although it did not reach statistical significance (p = 0.06). Conclusions:
PEC reduces the need for early hospitalization and IHD support in the break-in
period. The effect seems persistent as long as 6 months after commencement
of PD as reflected by the lower needs of extra NSFU.
Interleukin-2 receptor antagonist improves early post-transplant renal
function: results from single center experience
W.L. Chak, H.S. Wong, K.S. Choi, K.M. Wong, Y.H. Chan, C.Y. Cheung, Y.L.
Liu, H.W. Chan, K.F. Chau, C.S. Li
Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong.
Objective: International studies have shown that interleukin-2 receptor
antagonist (IL2RA) is effective in preventing acute rejection in renal transplant
recipients (RTR). We conducted a single center prospective study to assess its
efficacy in Chinese RTR. Methods: All RTR treated with IL2RA in a tertiary
transplant hospital were recruited from 1999 to 2001 (group 1). Its efficacy
was assessed by comparing with RTR who were either treated with anti-
thymocyte globulin (ATG) as induction therapy or without induction therapy
from 1997 to 2001 (group 2). Results: Group 1 comprised 24 RTR (13 male,
11 female) while group 2 recruited 33 controls (19 male, 14 female). Creatinine
upon hospital discharge was lower in group 1 (220 ( 127.4 +M) compared with
group 2 (356 ( 340.9 +M) (p = 0.02). There was also a trend of lower serum
creatinine at 6 and 12 months after renal transplantation but it did not reach
statistical significance. The initial post-transplant length of stay and first year
hospitalization rate as well as complications including the development of acute
and chronic rejections, patient and graft survival within 2 years and post-
transplant infection and malignancy showed no significant difference. The
incidence of biopsy proven acute rejection was 16% in group 1 compared to
9% in group 2 (p > 0.05). Conclusions: IL2RA is effective in Chinese RTR
with improvement of serum creatinine after renal transplantation without
increasing the risk of complications and hospitalizations.
